期刊文献+

利用PCR-SSP法研究肺腺癌细胞系A549、Calu-6的HLA-ABDR等位基因 被引量:2

Study on HLA-ABDR alleles in A549 and Calu-6 lung cancer cell lines with PCR-SSP
暂未订购
导出
摘要 背景和目的已有的研究表明人类白细胞抗原(HLA)在抗原呈递及T细胞识别抗原的过程中起关键作用,此外还与肿瘤细胞的免疫杀伤及免疫逃避有着密切的关系。本研究探讨了人肺腺癌细胞系A549、Calu6中HLA-A、HLA-B、HLA-DR等位基因的存在状况。方法分离A549、Calu6细胞DNA,分别行PCRSSP法扩增、电泳后紫外透射扫描,根据反应格局表对HLA-A、HLA-B、HLA-DR进行判定。结果A549与Calu6细胞中HLAA、HLAB基因较杂合子均有缺失,而HLA-DR基因无缺失。A549细胞HLAABDR的基因分型为HLA-A30、HLA-B44、HLA-DR7/HLADR53。Calu6细胞HLAAB-DR的基因分型为HLAA01、HLAB08、HLADR17/HLADR52。结论肺腺癌中存在HLAⅠ和HLAⅡ基因。HLAⅠ基因可能在肿瘤细胞传代过程中发生选择性丢失,而HLA-DR基因完整保留。检测肿瘤HL-A对了解其免疫学行为及建立肿瘤特异性杀伤淋巴细胞(CTL)模型具有重要意义。 Background and objective It has been confirmed that human leucocyte antigen (HLA) may play very important roles in the process of antigen presenting and antigen distinguishing. HLA has a close relationship with the immunity killing and immunity escape in cancer. HLA-ABDR alleles were detected in A549 and Calu-6 lung cancer cell lines by PCR-sequence specific primers (PCR-SSP) in this research. Methods DNA of A549 and Calu-6 was purified and PCR-SSP was practiced. Then the gel was scanned in ultra-violet. HLA-A, HLA-B and HLA-DR were determined with special response list. Results HLA-A and HLA-B in A549 and Calu-6 were not integral, but HLA-DR was integral. The genotype of HLA-ABDR for A549 was: HLA-A30, HLA-B44, HLA-DR7/HLA-DR53. The genotype of HLA-ABDR for Calu-6 was: HLA-A01, HLA-B08, HLA-DR17/HLA-DR52. Conclusion Human adenocarcinoma cell line exists both HLA-Ⅰ and HLA-Ⅱ genotypes. Selective loss of HLA-Ⅰ gene might be occured during tumor generation, but all the HLA-Ⅱgenes remain. Detection of tumor HLA is necessary to the acknowledgment of tumor immunology behavior and foundation of tumor specific cytotoxic T lymphocyte.
出处 《中国肺癌杂志》 CAS 2006年第2期113-116,共4页 Chinese Journal of Lung Cancer
基金 国家自然科学基金(No.30400440) 第三军医大学博士创新基金资助~~
关键词 肺腺癌细胞 人类白细胞抗原 PCR-SSP法 Lung adenocarcinoma Human leucocyte antigen PCR-SSP
  • 相关文献

参考文献10

  • 1Rimmelzwaan GF, Boon AC, Geelhoed-Mieras MM, et al. Human airway epithelial cells present antigen to influenza virus-specific CD^8+ CTL inefficiently after incubation with viral protein together with ISCOMATRIX. Vaccine,2004,22(21-22) : 2769-75.
  • 2Hanagiri T, Yoshino I, Takenoyama M, et al. Effects of interleukin-12 on the induction of cytotoxic T lymphocytes from the regional lymph node lymphocytes of patients with lung adenocarcinoma. Jpn J Cancer Res,1998,89(2) : 192-198.
  • 3Trojan A, Schultze JL, Witzens M, et al. Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies. Nat Med, 2000, 6 (6) :667-672.
  • 4Maleno I, Lopez-Nevot MA, Cabrera T, et al. Multiple mechanisms generate HLA class Ⅰ altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21. Cancer Immunol Immunother,2002,51(7) : 389-396.
  • 5Peltenburg LT, Dee R, Schrier PI. Downregulation of HLA class Ⅰ expression by c-myc in human melanoma is independent of enhancer A. Nucleic Acids Res,1993,21(5):1179-1185.
  • 6Xu M, Qiu G, Jiang Z, et al. Genetic modulation of tumor antigen presentation. Trends Biotechnol, 2000,18(4):167-172.
  • 7Rosenberg SA. Progress in human tumour immunology and immunotherapy. Nature,2001,411(6835):380-384.
  • 8Nukaya I, Yasumoto M, Iwasaki T, et al. Identification of HLA-A24 epitope peptides of carcinoembtyonic antigen which induce tumor-reactive cytotoxic T lymphocyte. Int J Cancer, 1999,80 (1) : 92-97.
  • 9Crowley NJ, Slingluff CL Jr, Darrow TL, et al. Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas. Cancer Res,1990,50(3) : 492-498.
  • 10Stevens EJ, Jacknin L, Robbins PF, et al. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition. J Immunol,1995,154(2) : 762-771.

同被引文献57

  • 1庄东刚,吴逸明,巴月.肺癌患者MAGE-A3抗原表达及HLA-I类基因分布的初步研究[J].河南预防医学杂志,2004,15(4):193-196. 被引量:1
  • 2徐亦益,刘祥麟,马洁羽,于晓宏,陈绍芳,胡华华.IFN-γ基因转导A549细胞对异种小鼠S_(180)抑瘤作用[J].肿瘤学杂志,2005,11(3):182-184. 被引量:2
  • 3Baba T, Hanagiri T, Ichiki Y, et al. Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B. Cancer Sci, 2007, 98(11): 1795-1802.
  • 4Kikuchi E, Yamazaki K, Torigoe T, et al. HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer. Cancer Sci, 2007, 98(9): 1424-1430.
  • 5Suzuki H, Higuchi M, Hasegawa T, et al. Tissue array analysis of the aberrant expression of HLA class I molecules in human non small cell lung cancer. Gan To Kagaku Ryoho, 2006, 33(12): 1713-1716.
  • 6Ramnath N, Tan D, Li Q, et al. Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival? Cancer Immunol Immunother, 2006, 55(8): 891-899.
  • 7Nagata Y, Hanagiri Tj Mizukami M, et al. Clinical significance of HLA class I alleles on postoperative prognosis of lung cancer patients in Japan. Lung Cancer, 2009, 65(1): 91-97.
  • 8Yie SM, Yang H, Ye SR, et al. Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer. Lung Cancer, 2007, 58(2): 267-274.
  • 9Paschen A, Arens N, Sucker A, et al. The coincidence of chromosome 15 aberrations and beta2-microglobulin gene mutations is causative for the total loss of human leukocyte antigen class I expression in melanoma. Clin Cancer Res, 2006, 12(11): 3297-3305.
  • 10Corrias MV, Occhino M, Croce M, et al. Lack of HLA-class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression. Tissue Antigens, 2001, 57(2): 110-117.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部